Science & Research

GW Pharmaceuticals is partnering up with New York’s Montefiore Medical Center to study CBDV, or cannabidivarin, as a treatment for autism.

Nine universities are receiving federal grants totaling $3 million to study the “potential pain-relieving properties” of minor cannabinoids and cannabis-sourced terpenes.

Yet another study has found that crime rates dropped near legal cannabis dispensaries in the years since cannabis was legalized in Colorado.

The UK’s Imperial College London is partnering with European medical cannabis company EMMAC for a study evaluating cannabis’ entourage effect as a pain relief option.

Researchers at Johns Hopkins University announced last week the formation of what is likely the world’s largest research facility dedicated to psilocybin and psychedelic medicinal research.

The DEA has announced an expansion of medical cannabis research options and a change in policy: hemp cultivators no longer need to register with the agency in light of the crop’s federal legalization.

A new study suggests that cannabis users generally live more enjoyable sex lives, and that cannabis could lead to more and better orgasms, healthier connections with one’s partner, and increased length of sexual activity.

Harvard researchers recently identified a specific cannabis flavonoid that was able to kill tumor cells in 70 percent of mice with pancreatic cancer.

Dr. Sue Sisley of the Scottsdale Research Institute is suing the DEA over hurdles to cannabis research — specifically, that government-sourced cannabis is nothing like the products being used en masse throughout legal states.

Yet another study has come out — this time, based in Colorado — suggesting that adult-use legalization policies do not lead to an uptick in teenage cannabis use.

A new study by the Stanford School of Medicine appears to contradict a commonly cited 2014 study that suggested medical cannabis legalization leads to a reduced rate of opioid overdoses.

A recent study covering 3,023 surveyed California parents found that parents who had used cannabis within the previous year were more likely to discipline their children. Note: this trend was reversed for “lifetime” cannabis users and the data used by researchers was collected in 2009.

Researchers at the University of Guelph in Ontario say they have identified pain-relieving cannabis flavonoids that are “30 times more powerful at reducing inflammation than Aspirin.”

Over 70 percent of patients enrolled in Minnesota’s medical cannabis program for PTSD say their symptoms are reduced.

Researchers from the Colorado State University Department of Soil and Crop Sciences believe that the proliferation of industrial hemp flowers could benefit pollinators, specifically the declining bee population.

Oregon State University’s new Global Hemp Innovation Center’s launch will combine research efforts and expertise from around the world to investigate hemp.

A team of researchers looking at post-legalization high school surveys found a decline among teenage cannabis use following the local legalization of medical and adult-use cannabis.

A team of Australian researchers says CBD could have potent antibiotic properties after lab tests showed the cannabinoid was killing bacteria, including those that are highly resistant to existing antibiotics.

Pennsylvania health officials have announced the first three clinical participants for the state’s medical cannabis research program.

A new report from Arcview Group and BDS Analytics suggests that the global cannabinoid market could reach $14.9 billion by the end of 2019 – a 36 percent increase over last year.

A recent study shows that nearly two-thirds of military veterans in California have replaced prescription medications with cannabis in the treatment of chronic pain, anxiety, PTSD, depression, and insomnia.

Archaeologists in China have discovered evidence of human cannabis use and cultivation dating back to 500 B.C.; researchers indicate that cannabis appears to have been used during burial rituals.

Australian researchers are seeking 300 participants for a years-long trial investigating the effectiveness of CBD as a treatment for veterans suffering from PTSD.

UC Riverside researchers have received a $744,000 grant to research the long-term impact of cannabis use on metabolic disorders like Type 2 diabetes.